Antonio Llinàs

2.5k total citations · 1 hit paper
37 papers, 1.9k citations indexed

About

Antonio Llinàs is a scholar working on Materials Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, Antonio Llinàs has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Materials Chemistry, 11 papers in Molecular Biology and 10 papers in Spectroscopy. Recurrent topics in Antonio Llinàs's work include Analytical Chemistry and Chromatography (10 papers), Crystallization and Solubility Studies (10 papers) and Computational Drug Discovery Methods (7 papers). Antonio Llinàs is often cited by papers focused on Analytical Chemistry and Chromatography (10 papers), Crystallization and Solubility Studies (10 papers) and Computational Drug Discovery Methods (7 papers). Antonio Llinàs collaborates with scholars based in Sweden, United Kingdom and Spain. Antonio Llinàs's co-authors include Jonathan M. Goodman, Robert C. Glen, Alleyn T. Plowright, Anders Hogner, Jonas Boström, Eric Wellner, Alex Avdeef, J. Burley, Michael I. Page and Karl Box and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Antonio Llinàs

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxadiazoles in Medicinal Chemistry

2011 484 citations Antonio Llinàs et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by Antonio Llinàs

Since Specialization

Citations

This map shows the geographic impact of Antonio Llinàs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Llinàs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Llinàs more than expected).

Fields of papers citing papers by Antonio Llinàs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Llinàs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Llinàs. The network helps show where Antonio Llinàs may publish in the future.

Co-authorship network of co-authors of Antonio Llinàs

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Llinàs. A scholar is included among the top collaborators of Antonio Llinàs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Llinàs. Antonio Llinàs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of protein aggregation on the immunogenicity of a human monoclonal antibody following pulmonary administration in mice 2024 ·International Journal of Pharmaceutics ·(unknown), (unknown), Sandra Gracin, Donatienne Tyteca, Francine Uwambayinema, François Huaux, Mariam Ibrahim, (unknown), Antonio Llinàs, Markus Fridén, Rita Vanbever	0
2	Case study: cremophor EL-based liquid formulations as simple substitutes for amorphous solid dispersions in early preclinical in vivo studies 2024 ·Journal of Pharmacy and Pharmacology ·Kalle Sigfridsson, (unknown), Antonio Llinàs	0
3	Blinded Predictions and Post Hoc Analysis of the Second Solubility Challenge Data: Exploring Training Data and Feature Set Selection for Machine and Deep Learning Models 2023 ·Journal of Chemical Information and Modeling ·(unknown), (unknown), (unknown), Vigneshwari Subramanian, Andrew Baxter, Ola Engkvist, Antonio Llinàs, Ekaterina L. Ratkova, Stephen D. Pickett, James L. McDonagh, David Scott Palmer	14
4	Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism 2023 ·Journal of Medicinal Chemistry ·Lena Ripa, Jenny Sandmark, Glyn A. Hughes, Igor L. Shamovsky, Anders Gunnarsson, (unknown), Antonio Llinàs, (unknown), (unknown), (unknown), Nils Pemberton, Mickael Mogemark, Yao Xiong, Qing Li, (unknown), Margareta Ek, Annika Åstrand	21
5	The Solid State Landscape of the Sildenafil Drug 2021 ·Journal of Pharmaceutical Sciences ·Rafael Barbas, Antonio Llinàs, Rafel Prohens	7
6	Multisolvent Models for Solvation Free Energy Predictions Using 3D-RISM Hydration Thermodynamic Descriptors 2020 ·Journal of Chemical Information and Modeling ·Vigneshwari Subramanian, Ekaterina L. Ratkova, David Scott Palmer, Ola Engkvist, Maxim V. Fedorov, Antonio Llinàs	12
7	Derisking Development by a Cocrystallization Screen of a Novel Selective Inhaled JAK-STAT inhibitor 2018 ·Crystal Growth & Design ·Antonio Llinàs, Rafael Barbas, Mercè Font-Bardı́a, (unknown), Rafel Prohens	2
8	Equilibrium solubility measurement of ionizable drugs – consensus recommendations for improving data quality 2016 ·ADMET & DMPK ·Alex Avdeef, Elisabet Fuguet, Antonio Llinàs, Clara Ràfols, Elisabeth Bosch, Gergely Völgyi, Tatjana Ž. Verbić, E.V. Boldyreva, Krisztina Takács‐Novák	110
9	Two New Polymorphic Cocrystals of Zafirlukast: Preparation, Crystal Structure, and Stability Relations 2015 ·Crystal Growth & Design ·Antonio Llinàs, Rafael Barbas, Mercè Font-Bardı́a, Michael J. Quayle, Sitaram P. Velaga, Rafel Prohens	8
10	Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor 2012 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Giordanetto, Andreas Wållberg, Laurent Knerr, Nidhal Selmi, (unknown), (unknown), (unknown), Staffan Karlsson, (unknown), Antonio Llinàs, Qing‐Dong Wang, Anders Lindqvist, (unknown), (unknown), Annika Åstrand, Göran Duker	4
11	Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Giordanetto, Laurent Knerr, Nidhal Selmi, Antonio Llinàs, Anders Lindqvist, Qing‐Dong Wang, (unknown), (unknown), (unknown), Kristina Nilsson, Gavin O’Mahony, (unknown), (unknown), Annika Åstrand, Göran Duker	5
12	Impact of Input Parameters on the Prediction of Hepatic Plasma Clearance Using the Well-Stirred Model 2010 ·Current Drug Metabolism ·Hong Wan, (unknown), Lars-Olof Larsson, Johan Ulander, Sheila Annie Peters, Boël Löfberg, Anna‐Lena Ungell, Mats Någård, Antonio Llinàs	17
13	Polymorph control: past, present and future 2008 ·Drug Discovery Today ·Antonio Llinàs, Jonathan M. Goodman	277
14	Solubility Challenge: Can You Predict Solubilities of 32 Molecules Using a Database of 100 Reliable Measurements? 2008 ·Journal of Chemical Information and Modeling ·Antonio Llinàs, Robert C. Glen, Jonathan M. Goodman	156
15	A new method for the reproducible generation of polymorphs: two forms of sulindac with very different solubilities 2007 ·Journal of Applied Crystallography ·Antonio Llinàs, Karl Box, J. Burley, Robert C. Glen, Jonathan M. Goodman	41
16	Amodiaquinium dichloride dihydrate from laboratory powder diffraction data 2006 ·Acta Crystallographica Section E Structure Reports Online ·Antonio Llinàs, L. Fábián, J. Burley, Jacco van de Streek, Jonathan M. Goodman	12
17	Thiol‐catalysed hydrolysis of cephalosporins and possible rate‐limiting amine anion expulsion 2004 ·Journal of Physical Organic Chemistry ·Antonio Llinàs, Bartolomé Vilanova, Michael I. Page	10
18	Intramolecular general acid catalysis in the aminolysis of β-lactam antibiotics 2004 ·Organic & Biomolecular Chemistry ·Antonio Llinàs, Michael I. Page	36
19	The role of a β-proton transfer donor in the degradation of benzylpenicillin 2001 ·Journal of Molecular Catalysis A Chemical ·Antonio Llinàs, Bartolomé Vilanova, Francisco Muñoz, Josefa Donoso	8
20	Thiol-catalysed hydrolysis of benzylpenicillin 2000 ·Journal of the Chemical Society Perkin Transactions 2 ·Antonio Llinàs, Josefa Donoso, Bartolomé Vilanova, Juan Frau, Francisco Muñoz, Michael I. Page	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact